CD79B and diffuse large B-cell lymphoma: Sensitivity to small molecules that inhibit all class I PI3Ks demonstrated a key role of PI3K in cell viability in a subset of ABC DLBCL lines with CD79B mutations and in GCB DLBCL lines with PTEN loss [10, 11].